Rhode Island Cancer Action Center

As Governor Daniel McKee prepares for his State of the State address, patient advocates are highlighting the results of a new report by the American Cancer Society Cancer Action Network (ACS CAN), which found that over 70% of commercially-insured patients encountered out-of-pocket expenses for follow-up breast cancer diagnostic tests in 2023. These follow-up tests, such as a diagnostic mammogram, MRI, ultrasound or biopsy, are medically recommended next steps to determine if an individual may or may not have cancer; however, barriers like cost can keep people from getting them.

PROVIDENCE – December 28, 2024 – Starting the first of the year, menthol flavored e-cigarette products will still be on store shelves across Rhode Island. The American Cancer Society Cancer Action Network (ACS CAN) and its team of advocates, including cancer survivors and patients, are disappointed with

Rhode Island lawmakers have taken the first step towards improving prescription drug affordability for cancer patients and others with chronic diseases.

Earlier this evening, the Rhode Island Senate voted in unanimous support of Senate Bill S799. This legislation would ensure Rhode Islanders receive the total value of prescription drug assistance available to them, improving affordable access to care for many with prescription drug needs